ArticleBeyoglu eye journal2025
An Ophthalmic Entity More Than Liver Disease, Alagille Syndrome: A Genetically Confirmed Case Report.
Article in Beyoglu eye journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alagille syndrome (ALGS) is a rare autosomal dominant disease that mainly affects the bile ducts and the liver. This syndrome may be associated with ophthalmic anomalies, but systemic diseases are often so obvious compared to ocular findings that many patients are referred to eye clinics after diagnosis. The diagnosis of ALGS is based on medical history and clinical findings. In this report, we describe and present a systemic disease of an undiagnosed ALGS based on eye findings. Papilledema and posterior embryotoxon were detected in the patient who was investigated due to headache. The diagnosis was made based on ophthalmological findings and was confirmed by genetic consultation. Missense mutations of the jagged canonical Notch ligand 1 gene located on chromosome 20p12.2 were detected. The patient benefited from treatment aimed at increasing intracranial pressure, and the etiology of symptoms related to other systems was clarified. The aim of this report is to support a clinical approach that evaluates possible common and rare comorbidities in ALGS from an ophthalmic perspective. We also emphasize the diversity of clinical presentation. ALGS affects multiple systems, so an integrative approach is important.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.